Jeet Mukherjee Score: 43
Analyst at
BTIG
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+38.1%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
55%
6 W / 5 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
83%
5 W / 1 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
17%
1 W / 5 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
17%
1 W / 5 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
60%
6 W / 4 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
55%
6 W / 5 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 |
Innate Pharma - ADR
IPHA
|
BUY |
$9.00
Est. +249%
|
$2.58 | $2.71 |
Pending
|
$2.11
-18.2%
|
| Aug 12, 2026 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$133.00
Est. +16%
|
$114.90 | $121.02 |
Pending
|
$118.55
+3.2%
|
| Jun 09, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$32.00
Est. +105%
|
$15.64 | $27.50 |
Pending
|
$25.32
+61.9%
|
| Dec 08, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$138.00
Est. +46%
|
$94.30 | $130.05 |
Pending
|
$117.28
+24.4%
|
| Oct 30, 2025 |
Arvinas Inc
ARVN
|
BUY |
$14.00
Est. +46%
|
$9.59 | $16.14 |
Target Met
|
$9.31
-2.9%
|
| Oct 22, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$75.00
Est. +29%
|
$58.32 | $130.05 |
Target Met
|
$117.28
+101.1%
|
| Oct 10, 2025 |
Perspective Therapeutics Inc
CATX
|
BUY |
$14.00
Est. +233%
|
$4.20 | $6.16 |
Pending
|
$3.12
-25.7%
|
| Sep 09, 2025 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$87.00
Est. +94%
|
$44.93 | $124.42 |
Target Met
|
$118.55
+163.9%
|
| Jun 26, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$59.00
Est. +27%
|
$46.47 | $130.05 |
Target Met
|
$117.28
+152.4%
|
| May 02, 2025 |
Arvinas Inc
ARVN
|
BUY |
$16.00
Est. +107%
|
$7.72 | $16.14 |
Bullseye Hit (±1%)
|
$9.31
+20.6%
|
| Dec 10, 2024 |
Arvinas Inc
ARVN
|
BUY |
$69.00
Est. +181%
|
$24.59 | $25.75 |
Miss
|
$9.31
-62.1%
|
Innate Pharma - ADR
IPHA
Aug 12, 2026
Signal & Target
BUY
$9.00
Start Price
$2.58
Best Price (1Y)
$2.71
Current Price
$2.11
Return
-18.2%
Monopar Therapeutics Inc
MNPR
Aug 12, 2026
Signal & Target
BUY
$133.00
Start Price
$114.90
Best Price (1Y)
$121.02
Current Price
$118.55
Return
+3.2%
Nurix Therapeutics Inc
NRIX
Jun 09, 2026
Signal & Target
BUY
$32.00
Start Price
$15.64
Best Price (1Y)
$27.50
Current Price
$25.32
Return
+61.9%
Kymera Therapeutics Inc
KYMR
Dec 08, 2025
Signal & Target
BUY
$138.00
Start Price
$94.30
Best Price (1Y)
$130.05
Current Price
$117.28
Return
+24.4%
Arvinas Inc
ARVN
Oct 30, 2025
Signal & Target
BUY
$14.00
Start Price
$9.59
Best Price (1Y)
$16.14
Current Price
$9.31
Return
-2.9%
Kymera Therapeutics Inc
KYMR
Oct 22, 2025
Signal & Target
BUY
$75.00
Start Price
$58.32
Best Price (1Y)
$130.05
Current Price
$117.28
Return
+101.1%
Perspective Therapeutics Inc
CATX
Oct 10, 2025
Signal & Target
BUY
$14.00
Start Price
$4.20
Best Price (1Y)
$6.16
Current Price
$3.12
Return
-25.7%
Monopar Therapeutics Inc
MNPR
Sep 09, 2025
Signal & Target
BUY
$87.00
Start Price
$44.93
Best Price (1Y)
$124.42
Current Price
$118.55
Return
+163.9%
Kymera Therapeutics Inc
KYMR
Jun 26, 2025
Signal & Target
BUY
$59.00
Start Price
$46.47
Best Price (1Y)
$130.05
Current Price
$117.28
Return
+152.4%
Arvinas Inc
ARVN
May 02, 2025
Signal & Target
BUY
$16.00
Start Price
$7.72
Best Price (1Y)
$16.14
Current Price
$9.31
Return
+20.6%
Arvinas Inc
ARVN
Dec 10, 2024
Signal & Target
BUY
$69.00
Start Price
$24.59
Best Price (1Y)
$25.75
Current Price
$9.31
Return
-62.1%